132 related articles for article (PubMed ID: 3897082)
21. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
Kopelman P; Bryson A; Hickling R; Rissanen A; Rossner S; Toubro S; Valensi P
Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
[TBL] [Abstract][Full Text] [Related]
22. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity.
Dulloo AG; Miller DS
Am J Clin Nutr; 1987 Mar; 45(3):564-9. PubMed ID: 3825983
[TBL] [Abstract][Full Text] [Related]
23. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
[TBL] [Abstract][Full Text] [Related]
24. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
Gadde KM; Yonish GM; Wagner HR; Foust MS; Allison DB
Int J Obes (Lond); 2006 Jul; 30(7):1138-42. PubMed ID: 16418753
[TBL] [Abstract][Full Text] [Related]
25. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Buemann B; Marckmann P; Christensen NJ; Astrup A
Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
[TBL] [Abstract][Full Text] [Related]
26. Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathomimetic stimulation.
Astrup A
Acta Endocrinol Suppl (Copenh); 1986; 278():1-32. PubMed ID: 3464154
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of thermogenic drugs.
Astrup A; Toubro S; Christensen NJ; Quaade F
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887
[TBL] [Abstract][Full Text] [Related]
28. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
29. Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population.
Cuellar GE; Ruiz AM; Monsalve MC; Berber A
Obes Res; 2000 Jan; 8(1):71-82. PubMed ID: 10678261
[TBL] [Abstract][Full Text] [Related]
30. Admixture of ephedrine to offset side effects of propofol: a randomized, controlled trial.
Austin JD; Parke TJ
J Clin Anesth; 2009 Feb; 21(1):44-9. PubMed ID: 19232940
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of bronchodilator effects of carbuterol and ephedrine.
James TD; Lyons HA
JAMA; 1979 Feb; 241(7):704-5. PubMed ID: 368368
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
33. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
[TBL] [Abstract][Full Text] [Related]
34. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.
Ryttig KR; Tellnes G; Haegh L; Bøe E; Fagerthun H
Int J Obes; 1989; 13(2):165-71. PubMed ID: 2545640
[TBL] [Abstract][Full Text] [Related]
35. Terbutaline and ephedrine in asthmatic children.
Blumberg MZ; Tinkelman DG; Ginchansky EJ; Blumberg BS; Taylor JC; Avner SE
Pediatrics; 1977 Jul; 60(1):14-9. PubMed ID: 327422
[TBL] [Abstract][Full Text] [Related]
36. Thermogenic, anti-obesity effects of bofu-tsusho-san in MSG-obese mice.
Yoshida T; Sakane N; Wakabayashi Y; Umekawa T; Kondo M
Int J Obes Relat Metab Disord; 1995 Oct; 19(10):717-22. PubMed ID: 8589765
[TBL] [Abstract][Full Text] [Related]
37. Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women.
Horton TJ; Geissler CA
Int J Obes; 1991 May; 15(5):359-66. PubMed ID: 1885260
[TBL] [Abstract][Full Text] [Related]
38. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
39. A one-year trial to assess the value of orlistat in the management of obesity.
James WP; Avenell A; Broom J; Whitehead J
Int J Obes Relat Metab Disord; 1997 Jun; 21 Suppl 3():S24-30. PubMed ID: 9225173
[TBL] [Abstract][Full Text] [Related]
40. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
